BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35698739)

  • 1. EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome.
    da Costa BHB; Becker AP; Neder L; Gonçalves PG; de Oliveira C; Polverini AD; Clara CA; Teixeira GR; Reis RM; Bidinotto LT
    J Pathol Transl Med; 2022 Jul; 56(4):205-211. PubMed ID: 35698739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
    Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
    Front Oncol; 2019; 9():1433. PubMed ID: 31921684
    [No Abstract]   [Full Text] [Related]  

  • 3. Low co-expression of epidermal growth factor receptor and its chaperone heat shock protein 90 is associated with worse prognosis in primary glioblastoma, IDH-wild-type.
    Sartori E; Langer R; Vassella E; Hewer E; Schucht P; Zlobec I; Berezowska S
    Oncol Rep; 2017 Oct; 38(4):2394-2400. PubMed ID: 28765916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer.
    de Oliveira C; Martins SFF; Gonçalves PG; Limone GA; Longatto-Filho A; Reis RM; Bidinotto LT
    Sci Rep; 2023 Nov; 13(1):19783. PubMed ID: 37957249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of brain regions associated with lower KPS and shorter survival time predicts a poor prognosis in glioma.
    Bao H; Wang H; Sun Q; Wang Y; Liu H; Liang P; Lv Z
    Front Neurol; 2023; 14():1264322. PubMed ID: 38111796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients.
    Saito T; Sugiyama K; Hama S; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K
    Neurosurg Rev; 2018 Apr; 41(2):621-628. PubMed ID: 28887717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
    Fujimoto K; Arita H; Satomi K; Yamasaki K; Matsushita Y; Nakamura T; Miyakita Y; Umehara T; Kobayashi K; Tamura K; Tanaka S; Higuchi F; Okita Y; Kanemura Y; Fukai J; Sakamoto D; Uda T; Machida R; Kuchiba A; Maehara T; Nagane M; Nishikawa R; Suzuki H; Shibuya M; Komori T; Narita Y; Ichimura K
    Acta Neuropathol; 2021 Aug; 142(2):323-338. PubMed ID: 34148105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification.
    Álvarez-Torres MDM; Fuster-García E; Juan-Albarracín J; Reynés G; Aparici-Robles F; Ferrer-Lozano J; García-Gómez JM
    BMC Cancer; 2022 Jan; 22(1):40. PubMed ID: 34991512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the prognostic potential of EGFL7 in pilocytic astrocytomas.
    Brunhara BB; Becker AP; Neder L; Gonçalves PG; de Oliveira C; Clara CA; Reis RM; Bidinotto LT
    Neuropathology; 2021 Feb; 41(1):21-28. PubMed ID: 33191640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of MGMT promoter methylation on the survival of TMZ treated
    Chai R; Li G; Liu Y; Zhang K; Zhao Z; Wu F; Chang Y; Pang B; Li J; Li Y; Jiang T; Wang Y
    Cancer Biol Med; 2021 Feb; 18(1):272-282. PubMed ID: 33628600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
    Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
    Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular classification of IDH-mutant glioblastomas based on gene expression profiles.
    Wu F; Chai RC; Wang Z; Liu YQ; Zhao Z; Li GZ; Jiang HY
    Carcinogenesis; 2019 Jul; 40(7):853-860. PubMed ID: 30877769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
    Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epigenetic Regulator Jumonji Domain-Containing Protein 6 (JMJD6) Is Highly Expressed but Not Prognostic in IDH-Wildtype Glioblastoma Patients.
    Rosager AM; Dahlrot RH; Sørensen MD; Bangsø JA; Hansen S; Kristensen BW
    J Neuropathol Exp Neurol; 2022 Jan; 81(1):54-60. PubMed ID: 34875075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
    Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
    BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort.
    Fukai J; Arita H; Umehara T; Yoshioka E; Shofuda T; Kanematsu D; Kodama Y; Mano M; Kinoshita M; Okita Y; Nonaka M; Uda T; Tsuyuguchi N; Sakamoto D; Uematsu Y; Nakao N; Mori K; Kanemura Y
    Brain Tumor Pathol; 2020 Apr; 37(2):50-59. PubMed ID: 32361941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas.
    Xie J; Qiao L; Deng G; Liang N; Xing L; Zhang J
    Ann Transl Med; 2022 Feb; 10(4):227. PubMed ID: 35280367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
    Velázquez Vega JE; Brat DJ; Ryken TC; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):143-164. PubMed ID: 33215342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Plasma Fibrinogen Levels are Associated with Malignant Phenotype and Worse Survival in Patients with Glioblastomas.
    Wang PF; Meng Z; Song HW; Yao K; Duan ZJ; Li SW; Yan CX
    J Cancer; 2018; 9(11):2024-2029. PubMed ID: 29896287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.